{"SPADE_UN_29975": {"Sequence Information": {"Peptide Name": "C16- Cathelicidin-BF-15 -AMD", "Sequence": "VKRFKKFFRKLKKSV", "Sequence Length": 15, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "B6D434", "uniprotUrl": "http://www.uniprot.org/uniprot/B6D434", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Aliphatic acid-conjugated antimicrobial peptides - potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability.", "Pubmed ID": "26083110", "Reference": "Org Biomol Chem. 2015;13:7673-7680", "Author": "Deng X, Qiu Q, Ma K, Wang X, Huang W, Qian H", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/26083110"}, {"Title": "Fatty acid chain modification enhances the serum stability of antimicrobial peptide B1 and activities against Staphylococcus aureus and Klebsiella pneumoniae", "Pubmed ID": "39616834", "Reference": "Bioorg Chem. 2025;154:108015", "Author": "Liao Z, Wu Y, Liu M, Zhang J, Cui Y, Zhangsun D, Luo S", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/39616834"}], "Mass": 1939.44, "PI": 12.0, "Net Charge": 8, "Hydrophobicity": -0.84, "Frequent Amino Acids": "KFR", "Absent Amino Acids": "ACDEGHIMNOPQTUWY", "Basic Residues": 8, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 9, "Positive Residues": 8, "Negative Residues": 0, "SPADE ID": "SPADE_UN_29975", "Similar Sequences": [{"SPADE_ID": "SPADE_N_06429", "Similarity": 1.0, "Sequence": "LVKRFKKFFRKLKKSVLL"}, {"SPADE_ID": "SPADE_N_06432", "Similarity": 1.0, "Sequence": "VKRFKKFFRKLKKSVL"}, {"SPADE_ID": "SPADE_N_06433", "Similarity": 1.0, "Sequence": "VKRFKKFFRKLKKSVLL"}], "Hemolytic Activity": "Human gastric epithelial cells GES-1:IC50=67.6±6.5 µM,Human embryonic kidney HEK293 cells:IC50=68.1±5.3 µM,Human erythrocytes:<10% Hemolysis=160 µM", "Target Organism": "Human breast adenocarcinoma MCF-7(IC50=1.9±0.2µM),Human breast adenocarcinoma MCF-7/Taxol(IC50=2.0±0.3µM),Human myelogenous leukemia K562(IC50=3.8±0.1µM),Human myelogenous leukemia K562/ADM(IC50=3.4±0.3µM),Human prostate cancer DU145(IC50=4.1±0.3µM),Staphylococcus aureus BNCC 186335(MIC=>32µM),Bacillus subtilis BNCC 109047 (MIC=>32µM),Acinetobacter baumannii BNCC 337173(MIC=>32µM),Klebsiella pneumoniae CMCC 46117(MIC=>32µM),Pseudomonas aeruginosa BNCC 125486(MIC=>32µM),Escherichia coli ATCC 25922(MIC=>32µM),Candida albicans CMCC 98001(MIC=>32µM),Candida albicans ATCC 10231(MIC=>32µM),Candida parapsilosis BNCC 336515(MIC=>32µM),Candida tropicalis BNCC 340288(MIC=>32µM),Cryptococcus neoformans BNCC 225501(MIC=>32µM)"}}}